Giorgio Cruccu

Giorgio Cruccu

Auto-generated profile, based on publicly available information

Giorgio Cruccu

Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
LBL. Bendtsen
L. Bendtsen
JZJ. M. Zakrzewska
J. M. Zakrzewska
JAJ. Abbott
J. Abbott
MBM. Braschinsky
M. Braschinsky
GSGiulia Di Stefano
Giulia Di Stefano
GCG. Cruccu
G. Cruccu
Background and purpose: Trigeminal neuralgia (TN) is an extremely painful condition which can be difficult to diagnose and treat. In Europe, TN patients are managed by many different specialities. Therefore, there is a great need for comprehensive European guidelines for the management of TN. The European Academy of Neurology asked an expert panel to develop recommendations for a series of questions that are essential for daily clinical management of patients with TN.Methods: A systematic review of the literature was performed and recommendations was developed based on GRADE, where feasible; if not, a good practice statement was given.Results: The use of the most recent classification system is recommended, which diagnoses TN as primary TN, either classical or idiopathic depending on the degree of neurovascular contact, or as secondary TN caused by pathology other than neurovascular contact. Magnetic resonance imaging (MRI), using a combination of three high‐resolution sequences, should be performed as part of the work‐up in TN patients, because no clinical characteristics can exclude secondary TN. If MRI is not possible, trigeminal reflexes can be used. Neurovascular contact plays an important role in primary TN, but demonstration of a neurovascular contact should not be used to confirm the diagnosis of TN. Rather, it may help to decide if and when a patient should be referred for microvascular decompression. In acute exacerbations of pain, intravenous infusion of fosphenytoin or lidocaine can be used. For long‐term treatment, carbamazepine or oxcarbazepine are recommended as drugs of first choice. Lamotrigine, gabapentin, botulinum toxin type A, pregabalin, baclofen and phenytoin may be used either alone or as add‐on therapy. It is recommended that patients should be offered surgery if pain is not sufficiently controlled medically or if medical treatment is poorly tolerated. Microvascular decompression is recommended as first‐line surgery in patients with classical TN. No recommendation can be given for choice between any neuroablative treatments or between them and microvascular decompression in patients with idiopathic TN. Neuroablative treatments should be the preferred choice if MRI does not demonstrate any neurovascular contact. Treatment for patients with secondary TN should in general follow the same principles as for primary TN. In addition to medical and surgical management, it is recommended that patients are offered psychological and nursing support.Conclusions: Compared with previous TN guidelines, there are important changes regarding diagnosis and imaging. These allow better characterization of patients and help in decision making regarding the planning of medical and surgical management. Recommendations on pharmacological and surgical management have been updated. There is a great need for future research on all aspects of TN, including pathophysiology and management.

1 August 2008 in Clinical Neurophysiology
Verified
Journal Article
Closed access
GCG. Cruccu
G. Cruccu
MAM.J. Aminoff
M.J. Aminoff
GCG. Curio
G. Curio
JGJ.M. Guerit
J.M. Guerit
RKR. Kakigi
R. Kakigi
LGL. Garcia-Larrea
L. Garcia-Larrea

5 September 2008 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
GCG. Cruccu
G. Cruccu
GGG. Gronseth
G. Gronseth
JAJ. Alksne
J. Alksne
CAC. Argoff
C. Argoff
MBM. Brainin
M. Brainin
JZJ. M. Zakrzewska
J. M. Zakrzewska
Several issues regarding diagnosis, pharmacological treatment, and surgical treatment of trigeminal neuralgia (TN) are still unsettled. The American Academy of Neurology and the European Federation of Neurological Societies launched a joint Task Force to prepare general guidelines for the management of this condition. After systematic review of the literature the Task Force came to a series of evidence‐based recommendations. In patients with TN MRI may be considered to identify patients with structural causes. The presence of trigeminal sensory deficits, bilateral involvement, and abnormal trigeminal reflexes should be considered useful to disclose symptomatic TN, whereas younger age of onset, involvement of the first division, unresponsiveness to treatment and abnormal trigeminal evoked potentials are not useful in distinguishing symptomatic from classic TN. Carbamazepine (stronger evidence) or oxcarbazepine (better tolerability) should be offered as first‐line treatment for pain control. For patients with TN refractory to medical therapy early surgical therapy may be considered. Gasserian ganglion percutaneous techniques, gamma knife and microvascular decompression may be considered. Microvascular decompression may be considered over other surgical techniques to provide the longest duration of pain freedom. The role of surgery versus pharmacotherapy in the management of TN in patients with multiple sclerosis remains uncertain.

20 August 2007 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
GCG. Cruccu
G. Cruccu
TAT. Z. Aziz
T. Z. Aziz
LGL. Garcia‐Larrea
L. Garcia‐Larrea
PHP. Hansson
P. Hansson
TJT. S. Jensen
T. S. Jensen
RTR. S. Taylor
R. S. Taylor
Pharmacological relief of neuropathic pain is often insufficient. Electrical neurostimulation is efficacious in chronic neuropathic pain and other neurological diseases. European Federation of Neurological Societies (EFNS) launched a Task Force to evaluate the evidence for these techniques and to produce relevant recommendations. We searched the literature from 1968 to 2006, looking for neurostimulation in neuropathic pain conditions, and classified the trials according to the EFNS scheme of evidence for therapeutic interventions. Spinal cord stimulation (SCS) is efficacious in failed back surgery syndrome (FBSS) and complex regional pain syndrome (CRPS) type I (level B recommendation). High‐frequency transcutaneous electrical nerve stimulation (TENS) may be better than placebo (level C) although worse than electro‐acupuncture (level B). One kind of repetitive transcranial magnetic stimulation (rTMS) has transient efficacy in central and peripheral neuropathic pains (level B). Motor cortex stimulation (MCS) is efficacious in central post‐stroke and facial pain (level C). Deep brain stimulation (DBS) should only be performed in experienced centres. Evidence for implanted peripheral stimulations is inadequate. TENS and r‐TMS are non‐invasive and suitable as preliminary or add‐on therapies. Further controlled trials are warranted for SCS in conditions other than failed back surgery syndrome and CRPS and for MCS and DBS in general. These chronically implanted techniques provide satisfactory pain relief in many patients, including those resistant to medication or other means.

13 July 2010 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
GCG. Cruccu
G. Cruccu
CSClaudia Sommer
Claudia Sommer
PAP. Anand
P. Anand
NAN. Attal
N. Attal
RBR. Baron
R. Baron
RTRolf-Detlef Treede
Rolf-Detlef Treede
Background and purpose:  We have revised the previous EFNS guidelines on neuropathic pain (NP) assessment, which aimed to provide recommendations for the diagnostic process, screening tools and questionnaires, quantitative sensory testing (QST), microneurography, pain‐related reflexes and evoked potentials, functional neuroimaging and skin biopsy.Methods:  We have checked and rated the literature published in the period 2004–2009, according to the EFNS method of classification for diagnostic procedures.Results:  Most of the previous recommendations were reinforced by the new studies. The main revisions relate to: (i) the new definition of NP and a diagnostic grading system; (ii) several new validated clinical screening tools that identify NP components, and questionnaires which assess the different types of NP; (iii) recent high‐quality studies on laser‐evoked potentials (LEPs) and skin biopsy.Conclusions:  History and bedside examination are still fundamental to a correct diagnosis, whilst screening tools and questionnaires are useful in indicating probable NP; QST is also useful for indicating the latter, and to assess provoked pains and treatment response. Amongst laboratory tests, LEPs are the best tool for assessing Aδ pathway dysfunction, and skin biopsy for assessing neuropathies with distal loss of unmyelinated nerve fibres.

4 March 2004 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
GCG. Cruccu
G. Cruccu
PAP. Anand
P. Anand
NAN. Attal
N. Attal
LGL. Garcia‐Larrea
L. Garcia‐Larrea
MHM. Haanpää
M. Haanpää
TJT. S. Jensen
T. S. Jensen
In September 2001, a Task Force was set up under the auspices of the European Federation of Neurological Societies with the aim of evaluating the existing evidence about the methods of assessing neuropathic pain and its treatments. This review led to the development of guidelines to be used in the management of patients with neuropathic pain. In the clinical setting a neurological examination that includes an accurate sensory examination is often sufficient to reach a diagnosis. Nerve conduction studies and somatosensory‐evoked potentials, which do not assess small fibre function, may demonstrate and localize a peripheral or central nervous lesion. A quantitative assessment of the nociceptive pathways is provided by quantitative sensory testing and laser‐evoked potentials. To evaluate treatment efficacy in a patient and in controlled trials, the simplest psychometric scales and quality of life measures are probably the best methods. A laboratory measure of pain that by‐passes the subjective report, and thus cognitive influences, is a hopeful aim for the future.